MARILIZABETH BIRK: Open Payments
NPI 1306453220 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$28,060 in 225 payments from 15 companies in 2025. Trend: 2023 $1,965 · 2024 $3,221 · 2025 $28,060
Speaker / faculty: $15,100Food & beverage: $5,584Travel & lodging: $4,867Consulting: $2,410Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 100 | $21,691 |
| E.R. Squibb & Sons, L.L.C. | 20 | $2,508 |
| Teva Pharmaceuticals USA, Inc. | 25 | $1,118 |
| Alkermes, Inc. | 8 | $686 |
| Janssen Pharmaceuticals, Inc | 11 | $493 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $376 |
| Otsuka America Pharmaceutical, Inc. | 15 | $372 |
| Vanda Pharmaceuticals Inc. | 10 | $233 |
| Neurocrine BioSciences, Inc. | 5 | $224 |
| Janssen Scientific Affairs, LLC | 2 | $133 |
Products named: VRAYLAR, COBENFY, INVEGA SUSTENNA, VIVITROL, UZEDY, AUSTEDO XR, CAPLYTA, FANAPT.
Industry payments across AZ — which companies pay providers there.
